Published on 25 March 2020
Current trends for biosimilars in the Latin American market
biologicals, biopharmaceuticals, biosimilars, Latin America
DOI: 10.5639/gabij.2020.0902.011
13.849 views
Published on 25 March 2020
biologicals, biopharmaceuticals, biosimilars, Latin America
DOI: 10.5639/gabij.2020.0902.011
13.849 views
Published on 05 September 2014
Author(s): Christian K Schneider, MD, Thijs J Giezen, PharmD, PhD, MSc
biosimilar, clinical safety, immunogenicity, pharmacovigilance
DOI: 10.5639/gabij.2014.0304.041
13.811 views
Published on 11 December 2015
Author(s): Professor Philip D Walson, MD, Robin Thorpe, PhD, FRCPath
biologicals, biosimilars, follow-on drugs, MENA (Middle East and North Africa), regulatory practice
DOI: 10.5639/gabij.2015.0404.039
13.789 views
Published on 12 February 2013
Author(s): Meenu Wadhwa, PhD, Robin Thorpe, PhD, FRCPath
biosimilar, comparability, quality, risk, safety
DOI: 10.5639/gabij.2013.0201.007
13.762 views
Published on 18 April 2013
Author(s): Saleh Karamah AL-Tamimi, BPharm, MPharm (ClinPharm), Mohamed Azmi Ahmad Hassali, PhD, Alian A Alrasheedy, BPharm(Hons), MPharm(Clin), BCPS
challenges, consumers, generic medicines, healthcare professionals, Yemen
DOI: 10.5639/gabij.2013.0202.017
13.738 views
Published on 20 January 2014
Author(s): Meenu Wadhwa, PhD, Robin Thorpe, PhD, FRCPath
biosimilar, EPAR, infliximab, monoclonal antibodies
DOI: 10.5639/gabij.2014.0301.004
13.405 views
Published on 27 June 2016
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2016.0502.023
13.339 views
Published on 29 October 2013
Author(s): Professor Philip D Walson, MD
biological products, pegylated interferons, World Health Organization (WHO)
DOI: 10.5639/gabij.2013.0204.043
13.318 views
Published on 12 June 2017
Author(s): Armando A Genazzani, DPhil, MD, Assistant Professor Gianluca Trifirò, MD, PhD, Ilaria Marcianò, MSc, Ylenia Ingrasciotta, MSc
biosimilars, comparative effectiveness, healthcare administrative databases, real world data, switching
DOI: 10.5639/gabij.2017.0603.023
13.290 views
Published on 07 February 2013
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2013.0201.006
13.273 views
Published on 21 April 2015
Author(s): Jacques Rottembourg, MD, Jessica Nasica-Labouze, PhD
biosimilars, generic drug repertory, generics, non-biological complex drug (NBCD)
DOI: 10.5639/gabij.2015.0403.029
13.088 views
Published on 06 February 2015
Author(s): Agnes V Klein, MD, DPH, Jian Wang, MD, PhD, Ally Pen, PhD
biologicals, biosimilars, clinical trials, extrapolation, immunogenicity, regulatory
DOI: 10.5639/gabij.2015.0401.009
13.052 views